EGAGenomicsCancer Genomicshttps://ega-archive.org/studies/EGAS00001007803EGAEGA study EGAS00001007803To profile the landscape of sebaceous tumours_RNAseqEGArestrictedNon-Polyadenylated RNA, ribonucleic acid, Acid, RNA, Ribonucleic, ribose nucleic acid, yeast nucleic acid, Ribonukleinsaeure, Non Polyadenylated RNA, Gene Products, ribonucleic acids, pentosenucleic acids, Non-Polyadenylated, Ribonucleic acids, RNS, Ribonucleic Acid, Non Polyadenylated, RNA Gene Products.WASLBP, VIP54, whole exome, RNA, Ribonucleic, Wiskott-Aldrich syndrome protein-interacting protein, Formol, DIP1, Malignant Neoplasm, ribose nucleic acid, Neoplasms, WISH, Benign Neoplasm, ribonucleic acids, RNS, Tumor, Malignant, 54 kDa vimentin-interacting protein, extracted material, AF3p21, Wasbp, MT, Benign, WASP-interacting SH3-domain protein, yeast nucleic acid, Ribonukleinsaeure, Methanal, Parafilm, DIP-1, Neoplasm, Gene Products, sequence, pentosenucleic acids, FORMALIN, Ribonucleic acids, rare (European definition), fixed, Non Polyadenylated, RNA Gene Products, 90 kDa N-WASP-interacting protein, ribonucleic acid, Acid, primary cancer, SH3 adapter protein SPIN90, Malignancy, Non Polyadenylated RNA, N-WASP-binding protein, Formaldehyd, Tissue, Exomes, Non-Polyadenylated, Oxomethane, Benign Neoplasms, Cancers, 90 kDa SH3 protein interacting with Nck, Ribonucleic Acid, malignant tumor, primary structure of sequence macromolecule, Methylene oxide, Malignant Neoplasms, RNA Gene Products., Non-Polyadenylated RNA, Neoplasias, aggressive behaviour, Formalin, Oxomethylene, malignant neoplasm, DIP, Wiskott-Aldrich syndrome protein-binding protein, aggression, ORF1, SPIN90, Malignancies, Diaphanous protein-interacting protein, Neoplasia, Dia-interacting protein 1, AF3P21, 54 kDa VacA-interacting protein, Cancer, TumorsfalseTo profile the landscape of sebaceous tumours RNAebaceous tumours are a rare cutaneous cancer with potential for aggressive behaviour. However, limited information is available on these cancers with few published cases. Here we wish to exome sequence these cancers to define the first genomic landscape for this malignancy. We will extract RNA from formalin-fixed, paraffin-embedded (FFPE) cores. Cores may be obtained from lesional and non-lesional tissues of primaries as well as matching metastases. The extracted RNA will be used for RNA sequencing.2024-05-28 13:27:07EGAS000010078039606EGAD00001015368EGAC00001000205